164 News

Your News Network

Menu
  • Sample Page
Menu

Alternative medicines regulations: Should AYUSH focus on safe-to-consume or efficacy? – Economic Times

Posted on October 27, 2021 by

<!–Uday Deb

–>

In the post-corona world, if there is a sector with a massive boom ahead, it is of alternative medicines. And as India is home to one of the oldest and highly advanced curative traditions in form of Ayurveda, it is a great opportunity that India can capitalize on, provided we have right policies in place at the earliest that will allow Ayurveda to fill the vacuum that allopathy is leaving behind.

If we don’t act soon, greedy market forces will take Ayurveda on the same path that allopathy has gone, i.e., abject commercialization sans social values.
The biggest stumbling block ahead for Ayurvedic medicines is to get legal recognition in a world where allopathic drug laws rule the roost.

As allopathic medicines pass through a process of clinical trails to get empirical confirmation for safe consumption and efficacy, the simple regulatory solution is to push Ayurvedic medicines on the same route for approval. The biggest advantage of taking such a regulatory route is that it will allow Ayurvedic medicines to access global market and if we play our IPR game properly, Indian manufacturers can enjoy the massive valuation that western drug companies have been thriving on.

The problem with allopathy-like validation for Ayurvedic medicines is that the curative logic and processes of Ayurveda are not exactly like allopathy where very direct cause-and-effect relationships are immediately visible in all medications. A lot of Ayurvedic medicines target chronic diseases and offer long-term benefits that a conventional clinical trial-based process will not be able to register or confirm. This means that establishing efficacy under the current for-allopathy framework will not be easy for all Ayurvedic medicines.

As allopathy and Ayurveda stem from different model of human body, it is also unfair to demand that a fish has to pass the test of climbing a tree.

So, what could be the way forward if we want Ayurveda to claim a place in the healthcare market?

At this point, AYUSH, the main regulatory authority has opted to solve the problem by going diametrically in opposite direction by accepting that traditional herbs and herbal formulation being in use since ages, they are exempted from seeking statutory approval used for allopathy drugs.

Such a policy may show short term gain, but what it can (and …….

Source: https://timesofindia.indiatimes.com/blogs/science-nomad/alternative-medicines-regulations-should-ayush-focus-on-safe-to-consume-or-efficacy/

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • How Long Does Samsung Support Its Phones? Let’s Find Out… – Know Your Mobile
  • Skincare Devices Market is expected to Garner at a 11.9% CAGR by 2030 | Cutera, Alma Lasers, Cynosure, Solta Medical – EIN News
  • Five steps to the ultimate winter skincare routine – Zululand Observer
  • The youth mental health crisis, how it’s affecting Maine’s young people, and what can be done to help – Maine Public
  • Online Classes During School Closures Are Good For Teenagers’ Mental Health – Forbes

Recent Comments

    Archives

    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021

    Categories

    • Alternative medicines
    • Android OS
    • E-sports
    • Exercise at home
    • Fitness sports
    • Hiking
    • Jogging
    • Lose weight
    • Massages
    • Meditation
    • Mental health
    • Muscle growth
    • Natural medicines
    • Psychology
    • Skincare
    • Test-001
    • Weightlifting
    • Yoga

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    ©2022 164 News | WordPress Theme by Superbthemes.com